Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Severe hemolysis and transfusion reactions after treatment with BGB-3111 and PD-1 antibody for Waldenström macroglobulinemia.

Othman J, Verner E, Tam CS, Huang J, Lin L, Hilger J, Trotman J, Gasiorowski R.

Haematologica. 2018 May;103(5):e223-e225. doi: 10.3324/haematol.2017.186817. Epub 2018 Feb 8. No abstract available.

2.

Subjective social status and its relationship to health and health behavior: comparing two different scales in university students.

Diehl K, Hoebel J, Sonntag D, Hilger J.

Int J Adolesc Med Health. 2017 Aug 25. pii: /j/ijamh.ahead-of-print/ijamh-2017-0079/ijamh-2017-0079.xml. doi: 10.1515/ijamh-2017-0079. [Epub ahead of print]

PMID:
28841574
3.

Eating behaviour of university students in Germany: Dietary intake, barriers to healthy eating and changes in eating behaviour since the time of matriculation.

Hilger J, Loerbroks A, Diehl K.

Appetite. 2017 Feb 1;109:100-107. doi: 10.1016/j.appet.2016.11.016. Epub 2016 Nov 15.

PMID:
27864073
4.

Feasibility and Patient Acceptance of Emergency Department-Based Influenza Vaccination in a Military Medical Center.

Hilger KA, Hilger JR, Putnam SD, Carstairs SD, Maves RC.

Mil Med. 2016 Aug;181(8):883-6. doi: 10.7205/MILMED-D-15-00074.

PMID:
27483528
5.

Micronutrient Intake in Healthy Toddlers: A Multinational Perspective.

Hilger J, Goerig T, Weber P, Hoeft B, Eggersdorfer M, Carvalho NC, Goldberger U, Hoffmann K.

Nutrients. 2015 Aug 18;7(8):6938-55. doi: 10.3390/nu7085316. Review.

6.

Nutrition and physical activity during the transition from adolescence to adulthood: further research is warranted.

Diehl K, Hilger J.

Int J Adolesc Med Health. 2015 Feb;27(1):101-4. doi: 10.1515/ijamh-2014-0010.

PMID:
24864299
7.

Dietary counselling for cardiovascular disease prevention in primary care settings: results from a German physician survey.

Görig T, Mayer M, Bock C, Diehl K, Hilger J, Herr RM, Schneider S.

Fam Pract. 2014 Jun;31(3):325-32. doi: 10.1093/fampra/cmu007. Epub 2014 Mar 17.

PMID:
24639564
8.

Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapy.

Berenson JR, Hilger JD, Yellin O, Dichmann R, Patel-Donnelly D, Boccia RV, Bessudo A, Stampleman L, Gravenor D, Eshaghian S, Nassir Y, Swift RA, Vescio RA.

Leukemia. 2014 Jul;28(7):1529-36. doi: 10.1038/leu.2014.27. Epub 2014 Jan 16.

PMID:
24429497
9.

A phase 1/2 study of oral panobinostat combined with melphalan for patients with relapsed or refractory multiple myeloma.

Berenson JR, Hilger JD, Yellin O, Boccia RV, Matous J, Dressler K, Ghazal HH, Jamshed S, Kingsley EC, Harb WA, Noga SJ, Nassir Y, Swift RA, Vescio R.

Ann Hematol. 2014 Jan;93(1):89-98. doi: 10.1007/s00277-013-1910-2. Epub 2013 Oct 18.

PMID:
24135804
10.

A systematic review of vitamin D status in populations worldwide.

Hilger J, Friedel A, Herr R, Rausch T, Roos F, Wahl DA, Pierroz DD, Weber P, Hoffmann K.

Br J Nutr. 2014 Jan 14;111(1):23-45. doi: 10.1017/S0007114513001840. Epub 2013 Aug 9. Review.

PMID:
23930771
11.

Safety and mid-term outcome of endovascular therapy for internal carotid artery disease: a 15-year experience at a single-centre angiology institution.

Ibrahim T, Karmann S, Schuster T, Fusaro M, Ott I, Böttiger C, Paschalidis M, Hilger JK, Poppert H, Theiss W, von Beckerath N.

Vasa. 2013 May;42(3):196-207. doi: 10.1024/0301-1526/a000257.

PMID:
23644371
12.

A global representation of vitamin D status in healthy populations: reply to comment by Saadi.

Wahl DA, Cooper C, Ebeling PR, Eggersdorfer M, Hilger J, Hoffmann K, Josse R, Kanis JA, Mithal A, Pierroz DD, Stenmark J, Stöcklin E, Dawson-Hughes B.

Arch Osteoporos. 2013;8:122. doi: 10.1007/s11657-013-0122-7. Epub 2013 Feb 1. No abstract available.

PMID:
23371520
13.

A global representation of vitamin D status in healthy populations.

Wahl DA, Cooper C, Ebeling PR, Eggersdorfer M, Hilger J, Hoffmann K, Josse R, Kanis JA, Mithal A, Pierroz DD, Stenmark J, Stöcklin E, Dawson-Hughes B.

Arch Osteoporos. 2012;7:155-72. doi: 10.1007/s11657-012-0093-0. Epub 2012 Aug 29.

PMID:
23225293
14.

A phase 2 study of pegylated liposomal doxorubicin, bortezomib, dexamethasone and lenalidomide for patients with relapsed/refractory multiple myeloma.

Berenson JR, Yellin O, Kazamel T, Hilger JD, Chen CS, Cartmell A, Woliver T, Flam M, Bravin E, Nassir Y, Vescio R, Swift RA.

Leukemia. 2012 Jul;26(7):1675-80. doi: 10.1038/leu.2012.51. Epub 2012 Feb 22.

PMID:
22354206
15.

A modified regimen of pegylated liposomal doxorubicin, bortezomib and dexamethasone (DVD) is effective and well tolerated for previously untreated multiple myeloma patients.

Berenson JR, Yellin O, Chen CS, Patel R, Bessudo A, Boccia RV, Yang HH, Vescio R, Yung E, Mapes R, Eades B, Hilger JD, Wirtschafter E, Hilger J, Nassir Y, Swift RA.

Br J Haematol. 2011 Dec;155(5):580-7. doi: 10.1111/j.1365-2141.2011.08884.x. Epub 2011 Sep 26.

PMID:
21950583
16.

Prognostic factors and jaw and renal complications among multiple myeloma patients treated with zoledronic acid.

Berenson JR, Yellin O, Crowley J, Makary A, Gravenor DS, Yang HH, Upadhyaya GH, Flinn IW, Staszewski H, Tiffany NM, Sanani S, Farber CM, Morganstein N, Bolejack V, Nassir Y, Hilger JD, Sefaradi A, Shamouelian A, Swift RA.

Am J Hematol. 2011 Jan;86(1):25-30. doi: 10.1002/ajh.21912.

17.

The development and implementation of a user-friendly priority setting tool for HIV care and treatment services in New York City.

Santella A, Laraque F, Hilger J, Camhi E.

J Community Health. 2011 Feb;36(1):158-65. doi: 10.1007/s10900-010-9293-y.

PMID:
20593229
18.

Phase 2 study of two sequential three-drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontline therapy for multiple myeloma.

Bensinger WI, Jagannath S, Vescio R, Camacho E, Wolf J, Irwin D, Capo G, McKinley M, Potts P, Vesole DH, Mazumder A, Crowley J, Becker P, Hilger J, Durie BG.

Br J Haematol. 2010 Feb;148(4):562-8. doi: 10.1111/j.1365-2141.2009.07981.x. Epub 2009 Nov 16.

PMID:
19919652
19.

A unified model of illusory and occluded contour interpolation.

Kalar DJ, Garrigan P, Wickens TD, Hilger JD, Kellman PJ.

Vision Res. 2010 Feb 8;50(3):284-99. doi: 10.1016/j.visres.2009.10.011. Epub 2009 Oct 21.

20.

Bortezomib, ascorbic acid and melphalan (BAM) therapy for patients with newly diagnosed multiple myeloma: an effective and well-tolerated frontline regimen.

Berenson JR, Yellin O, Woytowitz D, Flam MS, Cartmell A, Patel R, Duvivier H, Nassir Y, Eades B, Abaya CD, Hilger J, Swift RA.

Eur J Haematol. 2009 Jun;82(6):433-9. doi: 10.1111/j.1600-0609.2009.01244.x. Epub 2009 Feb 17.

PMID:
19226361
21.

Surface interpolation and 3D relatability.

Fantoni C, Hilger JD, Gerbino W, Kellman PJ.

J Vis. 2008 Nov 7;8(7):29.1-19. doi: 10.1167/8.7.29.

PMID:
19146261
22.

Safety and efficacy of bortezomib and melphalan combination in patients with relapsed or refractory multiple myeloma: updated results of a phase 1/2 study after longer follow-up.

Berenson JR, Yang HH, Vescio RA, Nassir Y, Mapes R, Lee SP, Wilson J, Yellin O, Morrison B, Hilger J, Swift R.

Ann Hematol. 2008 Aug;87(8):623-31. doi: 10.1007/s00277-008-0501-0. Epub 2008 May 8.

PMID:
18463870
23.

Seroprevalence of Bartonella henselae in cats in Germany.

Haimerl M, Tenter AM, Simon K, Rommel M, Hilger J, Autenrieth IB.

J Med Microbiol. 1999 Sep;48(9):849-56.

PMID:
10482296
24.

Delayed diagnosis of extrahepatic biliary injury.

Sherman HF, Hilger JS, Jones LM, McAuley CE, Barrette RR.

Eur J Surg. 1992 Oct;158(10):575-8. No abstract available.

PMID:
1360837
25.

Computed tomography in the diagnosis of cochlear otosclerosis.

Blakley BW, Hilger PA, Taylor S, Hilger J.

Otolaryngol Head Neck Surg. 1986 Apr;94(4):434-8.

PMID:
3086803
26.

A computerized nasal analysis system.

Hilger PA, Webster RC, Hilger JA, Smith RC.

Arch Otolaryngol. 1983 Oct;109(10):653-61.

PMID:
6615318
27.

Conchal bowl and postauricular flaps for reconstruction of the external auditory canal.

Wolfensberger M, Hilger PA, Hilger JA.

Otolaryngol Head Neck Surg. 1983 Aug;91(4):404-6.

PMID:
6415588
28.

Sequential changes in placental blood gases and pH during the hour following delivery.

Hilger JS, Holzman IR, Brown DR.

J Reprod Med. 1981 Jun;26(6):305-7.

PMID:
6788950
29.

Computerized axial-tomography in the preoperative evaluation of an angiofibroma.

Duckert LG, Carley RB, Hilger JA.

Laryngoscope. 1978 Apr;88(4):613-8.

PMID:
205744
30.

Symposium: computer assistance in health service. Summary.

Hilger JA.

Trans Am Acad Ophthalmol Otolaryngol. 1971 Sep-Oct;75(5):1153-5. No abstract available.

PMID:
5097827
31.

Presidential address.

Hilger JA.

Trans Am Acad Ophthalmol Otolaryngol. 1971 Jan-Feb;75(1):15-7. No abstract available.

PMID:
4927776
32.

Myringotomy in a child.

Hilger JR.

Postgrad Med. 1970 Jul;48(1):90-3. No abstract available.

PMID:
5448665
33.

The aging ear.

Hilger J.

Postgrad Med. 1968 Nov;44(5):219-23. No abstract available.

PMID:
5714858
34.

The internal lateral osteotomy in rhinoplasty.

Hilger JA.

Arch Otolaryngol. 1968 Aug;88(2):211-2. No abstract available.

PMID:
5662936
35.

Some general principles and methods in facial fracture management.

Hilger JA.

Laryngoscope. 1968 Jun;78(6):894-8. No abstract available.

PMID:
5662766
36.

Henry L. Williams, Jr., M.D.

Hilger JA.

J Lancet. 1967 Dec;87(12):485-6. No abstract available.

PMID:
4866875
37.

The objective evaluation of auditory function.

Long SV, Boies LR Jr, Hilger JA, Roth NA.

J Lancet. 1967 Jul;87(7):251-5. No abstract available.

PMID:
6042818
38.

Mid-facial fractures.

Hilger JA, Kusske DR.

Minn Med. 1967 Jun;50(6):961-71. No abstract available.

PMID:
6041526
39.

Editorials: Lawrence Randall Boies, M.D.

Hilger JA.

Minn Med. 1967 Jun;50(6):809-11. No abstract available.

PMID:
5342671
40.

The vertigo of endolymphatic hydrops.

Hilger JA.

Arch Otolaryngol. 1967 May;85(5):542-3. No abstract available.

PMID:
6023712
41.

Diagnosis and treatment of facial fractures.

Hilger JA, Cram BM.

GP. 1967 Mar;35(3):84-90. No abstract available.

PMID:
5609036
42.

Cochlear interrelationship.

Hilger JA, Boies LR Jr, Roth NA.

Ann Otol Rhinol Laryngol. 1966 Sep;75(3):844-8. No abstract available.

PMID:
5917652
43.

Objective study of the auditory process with particular reference to "cochleo-cochlear" cross-over function.

Hilger JA, Boies LR Jr, Hohmann A, Roth NA.

Laryngoscope. 1966 Aug;76(8):1353-64. No abstract available.

PMID:
5925175
44.

The facial and laryngeal injury.

Hilger JA, Kusske DR, Hohmann A, Cram BM.

J Lancet. 1966 Jun;86(6):262-73. No abstract available.

PMID:
5933309
45.

Office management of hearing problems.

Hilger JA.

Minn Med. 1966 Apr;49(4):561-5. No abstract available.

PMID:
5907231
46.

Percutaneous recording of cochlear microphonics in cats.

Hilger JA, Boies LR Jr, Roth NA.

Arch Otolaryngol. 1965 Dec;82(6):591-3. No abstract available.

PMID:
5846565
47.

Bell's palsy.

Hilger JA.

Minn Med. 1965 Nov;48(11):1463-7. No abstract available.

PMID:
5831818
48.

FATE OF IMPLANTS IN RATS.

HOHMANN A, HILGER JA, CARLEY R.

Ann Otol Rhinol Laryngol. 1964 Sep;73:791-806. No abstract available.

PMID:
14215952
49.

DIAGNOSIS OF GLOTTIC CARCINOMA.

HILGER JR.

Geriatrics. 1964 Mar;19:191-5. No abstract available.

PMID:
14126135
50.

FATE OF IMPLANTS IN RATS.

HOHMANN A, HILGER JA, CARLEY R.

Trans Am Otol Soc. 1964;52:200-16. No abstract available.

PMID:
14270889

Supplemental Content

Loading ...
Support Center